Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice

Human Molecular Genetics
Judith BlanzPaul Saftig

Abstract

Despite the progress in the treatment of lysosomal storage disorders (LSDs) mainly by enzyme replacement therapy, only limited success was reported in targeting the appropriate lysosomal enzyme into the brain. This prevents efficient clearance of neuronal storage, which is present in many of these disorders including alpha-mannosidosis. Here we show that the neuropathology of a mouse model for alpha-mannosidosis can be efficiently treated using recombinant human alpha-mannosidase (rhLAMAN). After intravenous administration of different doses (25-500 U/kg), rhLAMAN was widely distributed among tissues, and immunohistochemistry revealed lysosomal delivery of the injected enzyme. Whereas low doses (25 U/kg) led to a significant clearance (<70%) in visceral tissues, higher doses were needed for a clear effect in central and peripheral nervous tissues. A distinct reduction (<50%) of brain storage required repeated high-dose injections (500 U/kg), whereas lower doses (250 U/kg) were sufficient for clearance of stored substrates in peripheral neurons of the trigeminal ganglion. Successful transfer across the blood-brain barrier was evident as the injected enzyme was found in hippocampal neurons, leading to a nearly complete disappeara...Continue Reading

References

Jan 1, 1991·Annual Review of Biochemistry·E F Neufeld
Jun 19, 1989·Brain Research·M P Ten TusscherG F Vrensen
Dec 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·N N Aronson, M J Kuranda
Aug 1, 1989·Archives of Biochemistry and Biophysics·N N AronsonM J Kuranda
Oct 1, 1987·Archives of Disease in Childhood·A WillR F Stevens
Jan 2, 1995·American Journal of Medical Genetics·J K BennetL J Elsas
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·S U WalkleyS Wurzelmann
Jun 1, 1994·The Journal of Clinical Investigation·M S SandsE H Birkenmeier
Jul 10, 1997·Experimental Cell Research·L E KarageorgosP J Meikle
Aug 26, 1998·The Journal of Pediatrics·D A WallS Kotagal
Jan 23, 1999·American Journal of Human Genetics·T BergO Nilssen
Feb 5, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·U DunderI Mononen
Jul 23, 2004·Human Molecular Genetics·Diego Prieto RocesKurt von Figura
Aug 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Akihiko UrayamaWilliam A Banks
Sep 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Carole VoglerWilliam S Sly
Jun 13, 2006·Neurobiology of Disease·Karen CaeyenberghsRudi D'Hooge
Jun 30, 2006·Molecular Genetics and Metabolism·Allison C CrawleyJohn J Hopwood
Jul 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Akihiko UrayamaWilliam S Sly
Feb 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey H GrubbWilliam S Sly

❮ Previous
Next ❯

Citations

Jun 26, 2012·Journal of Neural Transmission·Qinfan LiWolf-Dieter Rausch
Feb 18, 2010·Journal of Inherited Metabolic Disease·Raphael Schiffmann
May 18, 2011·Journal of Inherited Metabolic Disease·Kim M Hemsley, John J Hopwood
May 10, 2011·Bone Marrow Transplantation·M MynarekK-W Sykora
Jan 29, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ulrich MatznerVolkmar Gieselmann
Apr 2, 2011·The Journal of Biological Chemistry·Frank MatthesUlrich Matzner
Sep 11, 2012·Brain : a Journal of Neurology·K KollmannT Braulke
Jun 22, 2013·Orphanet Journal of Rare Diseases·Michael BeckDag Malm
Feb 8, 2014·Orphanet Journal of Rare Diseases·Laurent BonessoCharlotte Hinault
Sep 30, 2010·Human Molecular Genetics·Vinicia Assunta PolitoMaria Pia Cosma
Oct 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Michelle RothaugJudith Blanz
Aug 24, 2010·Neuromolecular Medicine·Matthias Eckhardt
Jun 1, 2012·Drug Delivery and Translational Research·Patricia I Dickson
Dec 16, 2010·Journal of Neuropathology and Experimental Neurology·Markus DammeJudith Blanz
Nov 28, 2015·Neurochemical Research·Erica B SherryIn-Young Choi
Apr 1, 2017·The International Journal of Biochemistry & Cell Biology·Anna TasegianTommaso Beccari
Mar 21, 2017·Journal of Inherited Metabolic Disease·Markus Ries
Dec 15, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Akihiko UrayamaWilliam A Banks
May 19, 2018·International Journal of Molecular Sciences·Maria Rachele CeccariniTommaso Beccari
Jan 28, 2016·Annals of Clinical and Translational Neurology·Markus DammeJudith Blanz
Oct 11, 2017·Human Molecular Genetics·Kareen BartschBjörn Rabe
Apr 13, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Li OuChester B Whitley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Jeffrey H GrubbWilliam S Sly
Proceedings of the National Academy of Sciences of the United States of America
Carole VoglerWilliam S Sly
Molecular Therapy : the Journal of the American Society of Gene Therapy
Ulrich MatznerVolkmar Gieselmann
© 2022 Meta ULC. All rights reserved